Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

The association of psychedelic use and opioid use disorders among illicit users in the United States.

Pisano VD, Putnam NP, Kramer HM, Franciotti KJ, Halpern JH, Holden SC.

J Psychopharmacol. 2017 May;31(5):606-613. doi: 10.1177/0269881117691453. Epub 2017 Feb 14.

PMID:
28196428
2.

A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD.

Halpern JH, Lerner AG, Passie T.

Curr Top Behav Neurosci. 2018;36:333-360. doi: 10.1007/7854_2016_457. Review.

PMID:
27822679
3.

Effects of 3,4-Methylenedioxymethamphetamine on Patient Utterances in a Psychotherapeutic Setting.

Corey VR, Pisano VD, Halpern JH.

J Nerv Ment Dis. 2016 Jul;204(7):519-23. doi: 10.1097/NMD.0000000000000499.

PMID:
26998697
4.

Reply to: 'illicit drugs and cluster headache: an inevitable discussion'.

Halpern JH.

Cephalalgia. 2013 May;33(7):496-7. doi: 10.1177/0333102413480753. Epub 2013 Mar 8. No abstract available.

PMID:
23475296
5.

The right medicine for World Drug Day.

Halpern JH.

Indian J Med Res. 2012 Jun;135(6):801-2. No abstract available.

6.

Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence.

Passie T, Emrich HM, Karst M, Brandt SD, Halpern JH.

Drug Test Anal. 2012 Jul-Aug;4(7-8):649-59. doi: 10.1002/dta.1377. Epub 2012 Jun 26. Review.

PMID:
22736575
7.

Genuine and drug-induced synesthesia: a comparison.

Sinke C, Halpern JH, Zedler M, Neufeld J, Emrich HM, Passie T.

Conscious Cogn. 2012 Sep;21(3):1419-34. doi: 10.1016/j.concog.2012.03.009. Epub 2012 Apr 21. Review.

PMID:
22521474
8.

Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.

Halpern JH, Sherwood AR, Hudson JI, Gruber S, Kozin D, Pope HG Jr.

Addiction. 2011 Apr;106(4):777-86. doi: 10.1111/j.1360-0443.2010.03252.x. Epub 2011 Feb 15.

9.

The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series.

Karst M, Halpern JH, Bernateck M, Passie T.

Cephalalgia. 2010 Sep;30(9):1140-4. doi: 10.1177/0333102410363490. Epub 2010 Mar 26. No abstract available.

PMID:
20713566
10.

Importance of psychiatric confounding in non-randomized studies of heavy ecstasy users.

Krebs TS, Johansen PØ, Jerome L, Halpern JH.

Psychol Med. 2009 May;39(5):876-8. doi: 10.1017/S0033291708005096. Epub 2009 Feb 12. No abstract available.

PMID:
19215629
11.

The pharmacology of lysergic acid diethylamide: a review.

Passie T, Halpern JH, Stichtenoth DO, Emrich HM, Hintzen A.

CNS Neurosci Ther. 2008 Winter;14(4):295-314. doi: 10.1111/j.1755-5949.2008.00059.x. Review.

12.

"Enhanced" interrogation of detainees: do psychologists and psychiatrists participate?

Halpern AL, Halpern JH, Doherty SB.

Philos Ethics Humanit Med. 2008 Sep 25;3:21. doi: 10.1186/1747-5341-3-21.

13.

Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament.

Halpern JH, Sherwood AR, Passie T, Blackwell KC, Ruttenber AJ.

Med Sci Monit. 2008 Aug;14(8):SR15-22.

PMID:
18668010
14.

Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth).

Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH.

Addiction. 2008 Jun;103(6):1048-50. doi: 10.1111/j.1360-0443.2008.02209.x.

15.

Response of cluster headache to psilocybin and LSD.

Sewell RA, Halpern JH, Pope HG Jr.

Neurology. 2006 Jun 27;66(12):1920-2.

PMID:
16801660
16.

Psychological and cognitive effects of long-term peyote use among Native Americans.

Halpern JH, Sherwood AR, Hudson JI, Yurgelun-Todd D, Pope HG Jr.

Biol Psychiatry. 2005 Oct 15;58(8):624-31.

PMID:
16271313
17.

Hallucinogenic botanicals of America: a growing need for focused drug education and research.

Halpern JH, Sewell RA.

Life Sci. 2005 Dec 22;78(5):519-26. Epub 2005 Sep 26. Review.

PMID:
16188280
18.

Now is the time for AAPL to demonstrate leadership by advocating positions of social importance.

Halpern AL, Halpern JH, Freedman AM.

J Am Acad Psychiatry Law. 2004;32(2):180-3.

PMID:
15281422
19.

Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs.

Halpern JH, Pope HG Jr, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D.

Drug Alcohol Depend. 2004 Aug 16;75(2):135-47.

PMID:
15276218
20.

Hallucinogens and dissociative agents naturally growing in the United States.

Halpern JH.

Pharmacol Ther. 2004 May;102(2):131-8. Review.

PMID:
15163594
21.

Use of schizophrenia as a metaphor in US newspapers.

Duckworth K, Halpern JH, Schutt RK, Gillespie C.

Psychiatr Serv. 2003 Oct;54(10):1402-4.

PMID:
14557528
22.

Hallucinogens: an update.

Halpern JH.

Curr Psychiatry Rep. 2003 Oct;5(5):347-54. Review.

PMID:
13678554
23.

Diminished interleukin-6 response to proinflammatory challenge in men and women after intravenous cocaine administration.

Halpern JH, Sholar MB, Glowacki J, Mello NK, Mendelson JH, Siegel AJ.

J Clin Endocrinol Metab. 2003 Mar;88(3):1188-93.

PMID:
12629105
24.

Hallucinogen persisting perception disorder: what do we know after 50 years?

Halpern JH, Pope HG Jr.

Drug Alcohol Depend. 2003 Mar 1;69(2):109-19. Review.

PMID:
12609692
25.

Hallucinogens on the Internet: a vast new source of underground drug information.

Halpern JH, Pope HG Jr.

Am J Psychiatry. 2001 Mar;158(3):481-3.

PMID:
11229993
26.

Treatment of attention-deficit/hyperactivity disorder.

Halpern JH.

JAMA. 1999 Apr 28;281(16):1491. No abstract available. Erratum in: JAMA 1999 Jul 14;282(2):136.

PMID:
10227317
27.

Do hallucinogens cause residual neuropsychological toxicity?

Halpern JH, Pope HG Jr.

Drug Alcohol Depend. 1999 Feb 1;53(3):247-56. Review.

PMID:
10080051
28.

Supplemental Content

Loading ...
Support Center